Association Between Serum Fatty Acids Profile and MetScore in Women with Severe Obesity

Overview

Journal Nutrients

Date 2024 Oct 26

PMID 39458502

Authors

Emilly Santos Oliveira

Fabiana Martins Kattah

Glaucia Carielo Lima

Maria Aderuza Horst

Nayra Figueiredo

Gislene Batista Lima

Renata Guimaraes Moreira Whitton

Gabriel Inacio de Morais Honorato de Souza

Lila Missae Oyama

Erika Aparecida Silveira

Flavia Campos Corgosinho

Affiliations

Soon will be listed here.

Abstract

Background: Metabolic syndrome (MetS) is a set of conditions associated with an increased cardiovascular risk. Several serum fatty acids (FAs) seem to play an essential role in the development of cardiometabolic diseases and mortality. Thus, it is imperative to explore the impact of FAs on MetS parameters, using an early MetS screening tool such as MetScore, which is readily available in clinical practice.

Aim: The aim of this study was to assess the potential correlation between serum FAs and cardiovascular risk using a MetScore.

Methods: This cross-sectional study involved 41 women with severe obesity. The MetScore was calculated, and participants were categorized into high- and low-cardiovascular-risk groups based on the median MetScore value. Gas chromatography was used to quantify serum FAs. Generalized Linear Models were used to compare group means. The association was assessed through simple logistic regression, and an adjusted logistic regression was conducted to validate the association between Metscore and serum FAs.

Results: The high-cardiovascular-risk group exhibited elevated values of HOMA-IR, palmitic, oleic, cis-vaccenic, and monounsaturated fatty acids, as well as the SCD-18C, indicating a heightened cardiovascular risk. Conversely, HDL-c, QUICK, gamma-linolenic, and eicosatetraenoic fatty acids showed lower values compared to the low-risk group.

Conclusions: Women with severe obesity and high cardiovascular risk have lower values of some omega-3 and omega-6 FAs, considered cardioprotective and anti-inflammatory, and have higher lipogenic activity and FAs, correlated with high cardiovascular risk. These findings emphasize the need to address lipid metabolism in this population as a therapeutic target to reduce cardiovascular risk. Future research should explore clinical interventions that modulate fatty acid metabolism to mitigate cardiometabolic complications.

References

Alsharari Z, Leander K, Sjogren P, Carlsson A, Cederholm T, de Faire U . Association between carbohydrate intake and fatty acids in the de novo lipogenic pathway in serum phospholipids and adipose tissue in a population of Swedish men. Eur J Nutr. 2019; 59(5):2089-2097. PMC: 7351873. DOI: 10.1007/s00394-019-02058-6. View

Lounis M, Escoula Q, Veillette C, Bergeron K, Ntambi J, Mounier C . SCD1 deficiency protects mice against ethanol-induced liver injury. Biochim Biophys Acta. 2016; 1861(11):1662-1670. DOI: 10.1016/j.bbalip.2016.07.012. View

Swinburn B, Kraak V, Allender S, Atkins V, Baker P, Bogard J . The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019; 393(10173):791-846. DOI: 10.1016/S0140-6736(18)32822-8. View

Malta D, da Silva A, Tonaco L, Freitas M, Velasquez-Melendez G . [Time trends in morbid obesity prevalence in the Brazilian adult population from 2006 to 2017]. Cad Saude Publica. 2019; 35(9):e00223518. DOI: 10.1590/0102-311X00223518. View

Surette M, Koumenis I, Edens M, Tramposch K, Chilton F . Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin Ther. 2003; 25(3):948-71. DOI: 10.1016/s0149-2918(03)80116-9. View

Svendsen K, Olsen T, Nordstrand Rusvik T, Ulven S, Holven K, Retterstol K . Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health. Lipids Health Dis. 2020; 19(1):102. PMC: 7243306. DOI: 10.1186/s12944-020-01282-y. View

Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A . Indirect insulin resistance detection: Current clinical trends and laboratory limitations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163(3):187-199. DOI: 10.5507/bp.2019.021. View

Stern S, Williams K, Ferrannini E, DeFronzo R, Bogardus C, Stern M . Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005; 54(2):333-9. DOI: 10.2337/diabetes.54.2.333. View

Tian Y, Zhang J, Li M, Shang J, Bai X, Zhang H . Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023; 14:1077590. PMC: 10102484. DOI: 10.3389/fendo.2023.1077590. View

10.

Perna M, Hewlings S . Saturated Fatty Acid Chain Length and Risk of Cardiovascular Disease: A Systematic Review. Nutrients. 2023; 15(1). PMC: 9823926. DOI: 10.3390/nu15010030. View

11.

Ravaut G, Legiot A, Bergeron K, Mounier C . Monounsaturated Fatty Acids in Obesity-Related Inflammation. Int J Mol Sci. 2021; 22(1). PMC: 7795523. DOI: 10.3390/ijms22010330. View

12.

Silveira E, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C . Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obes Rev. 2020; 22(1):e13088. PMC: 7757158. DOI: 10.1111/obr.13088. View

13.

Ichihara K, Fukubayashi Y . Preparation of fatty acid methyl esters for gas-liquid chromatography. J Lipid Res. 2009; 51(3):635-40. PMC: 2817593. DOI: 10.1194/jlr.D001065. View

14.

Hodson L, Skeaff C, Fielding B . Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008; 47(5):348-80. DOI: 10.1016/j.plipres.2008.03.003. View

15.

Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang M . Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011; 12(5):408-15. PMC: 4090391. DOI: 10.1038/ni.2022. View

16.

Yu E, Hu P, Mehta S . Plasma fatty acids in de novo lipogenesis pathway are associated with diabetogenic indicators among adults: NHANES 2003-2004. Am J Clin Nutr. 2018; 108(3):622-632. PMC: 6915820. DOI: 10.1093/ajcn/nqy165. View

17.

Hingorjo M, Zehra S, Imran E, Qureshi M . Neck circumference: A supplemental tool for the diagnosis of metabolic syndrome. J Pak Med Assoc. 2016; 66(10):1221-1226. View

18.

Balatskyi V, Dobrzyn P . Role of Stearoyl-CoA Desaturase 1 in Cardiovascular Physiology. Int J Mol Sci. 2023; 24(6). PMC: 10059744. DOI: 10.3390/ijms24065531. View

19.

Patel P, Sharp S, Jansen E, Luben R, Khaw K, Wareham N . Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition.... Am J Clin Nutr. 2010; 92(5):1214-22. DOI: 10.3945/ajcn.2010.29182. View

20.

Wrzosek M, Zawadzka Z, Sawicka A, Bobrowska-Korczak B, Bialek A . Impact of Fatty Acids on Obesity-Associated Diseases and Radical Weight Reduction. Obes Surg. 2021; 32(2):428-440. PMC: 8794933. DOI: 10.1007/s11695-021-05789-w. View